首页> 美国卫生研究院文献>Journal of Breast Cancer >Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer

【2h】

Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer

机译：瘦素作为雌激素受体阳性乳腺癌的潜在靶标。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeLeptin is a potent adipokine that plays a significant role in tumor development and the progression of breast cancer. The aim of this study was to evaluate whether leptin affects the response to tamoxifen treatment in estrogen receptor (ER)-positive breast cancer cells.

机译：目的瘦素是一种有效的脂肪因子，在肿瘤的发展和乳腺癌的发展中起着重要的作用。这项研究的目的是评估瘦素是否影响雌激素受体（ER）阳性乳腺癌细胞对他莫昔芬治疗的反应。

著录项

期刊名称 Journal of Breast Cancer
作者
Cha Kyong Yom; Kyung-Min Lee; Wonshik Han; Sung-Won Kim; Hee Sung Kim; Byung In Moon; Ku-Young Jeong; Seock-Ah Im; Dong-Young Noh;
展开▼
作者单位

展开▼
年(卷),期 2013(16),2
年度 2013
页码 138–145
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词
Breast neoplasms Hormone resistance Leptin;

机译：乳腺肿瘤;激素抵抗;瘦素;

相似文献

外文文献
中文文献
专利

1. Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer [J] . Yom Cha Kyong, Lee Kyung-Min, Han Wonshik, Journal of Breast Cancer . 2013 ,第2期

机译：瘦素作为雌激素受体阳性乳腺癌的潜在靶标。
2. Gene signatures and potential therapeutic targets of amino acid metabolism in estrogen receptor-positive breast cancer [J] . Chih-Yang Wang, Tzu-Yang Weng, Wei-Ching Chen, American Journal of Cancer Research . 2020 ,第1期

机译：雌激素受体阳性乳腺癌中氨基酸代谢的基因签名及潜在治疗靶
3. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. [J] . Li CI, Daling JR, Porter PL Journal of Clinical Oncology . 2009 ,第32期

机译：诊断为雌激素受体阳性浸润性乳腺癌的妇女中，可能改变的生活方式因素与第二原发对侧乳腺癌风险之间的关系。
4. Estrogen Receptor-Positive Breast Cancer: Traditional Prognostics, Molecular Pathology: A New Breast Cancer Taxonomy and 21st Century Personalized Prognostic and Predictive Assays [C] . Frederick L. Baehner International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：雌激素受体阳性乳腺癌：传统预测，分子病理：新的乳腺癌分类和21世纪个性化预测和预测测定
5. The SERM, arzoxifene, and the rexinoid, LG100268, cooperate to prevent estrogen receptor-positive and -negative breast cancer as well as colon cancer. [D] . Rendi, Mara H. 2004

机译：SERM，arzoxifene和类维生素LG100268共同预防雌激素受体阳性和阴性乳腺癌以及结肠癌。
6. Gene signatures and potential therapeutic targets of amino acid metabolism in estrogen receptor-positive breast cancer [O] . Chih-Yang Wang, Chung-Chieh Chiao, Nam Nhut Phan, 2020

机译：雌激素受体阳性乳腺癌的氨基酸代谢的基因特征和潜在治疗靶标
7. Estrogen receptor signaling as a target for novel breast cancer therapeutics. : new targets in estradiol receptor-positive breast cancers [O] . Renoir, Jack-Michel, Marsaud, Véronique, Lazennec, Gwendal 2013

机译：雌激素受体信号转导作为新型乳腺癌治疗的靶标。：雌二醇受体阳性乳腺癌的新靶标
8. Regulated Ubiquitinylation-Dependent Corepressor and Coactivator Complex Exchange as a Potential Target in Estrogen-Dependent Breast Cancer [R] . Chang, C. S. 2006

机译：调节泛素化依赖的辅助抑制因子和辅激活因子复合物交换作为雌激素依赖性乳腺癌的潜在靶点

Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer

摘要

著录项

相似文献

相关主题

期刊订阅